African study confirms dolutegravir for second-line treatment and supports recycling of tenofovir
Dolutegravir or darunavir/ritonavir are equally effective in second-line treatment, even in the presence of high-level resistance to NRTIs included in the regimen, a large randomised study carried out in three African countries has found. Furthermore, tenofovir and lamivudine can be recycled in second-line treatment even in people with high-level resistance to the drugs, without undermining… Read More »
